Skip to main content
HR 7640 117th Congress House Health

To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as "orphan drugs").

Introduced: May 3, 2022 Introduced by: Bilirakis, Gus M. Republican · Florida See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 3, 2022
Referred to the House Committee on Energy and Commerce.
May 3, 2022
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

This bill reauthorizes through FY2027 the Food and Drug Administration's Orphan Products Grants Program, which supports clinical research and product development for rare diseases and conditions.

What's happening now May 3, 2022

Referred to the House Committee on Energy and Commerce.

 Related & companion bills 1
  • S 4348 Related bill FDASLA Act of 2022
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 7640: To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as "orphan drugs").. 117th Congress. Open America. https://openamerica.io/bill/117-HR-7640/
MLA
"H.R. 7640: To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as "orphan drugs").." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-7640/.
Bluebook (legal)
H.R. 7640, 117th Cong. (2026), https://openamerica.io/bill/117-HR-7640/.
Markdown link
[H.R. 7640: To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as "orphan drugs").](https://openamerica.io/bill/117-HR-7640/)
Report a problem